(Reuters) - Citigroup (NYSE:C) downgraded its stance on U.S. equities and slashed its S&P 500 index target for this year as it expects tariff uncertainty to hurt corporate America’s earnings.Citi joined a string of brokerages, including Goldman Sachs and BofA, in slashing their benchmark index target below the 6000 mark. Citi’s current year-end target stands at 5800, below its previous e ...
(Reuters) - The sweeping tariffs imposed by U.S. President Donald Trump since April 2 and the subsequent pauses on some of them have generated uncertainty for companies worldwide, causing some of them to withdraw or refrain from giving a financial guidance.Here is a list of companies that have made such moves:AEROSPACE & DEFENSEDELTA AIR LINESThe U.S. carrier on April 9 withdrew its financial ...
Investing.com -- Barclays strategists upgraded Quality European stocks to Positive while lowering Value to Neutral amid increasing recession risks.The move comes after global equity markets experienced declines in March and continued to face challenges into April, affected by tariff announcements and policy uncertainties.“The 90-day pause on higher reciprocal tariffs was a welcome reprieve, but ...
(Reuters) -Swiss generic drug manufacturer Sandoz (SIX:SDZ) said on Monday it had filed an antitrust lawsuit in the United States against Amgen (NASDAQ:AMGN) over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).Sandoz alleges Amgen blocked competition from more cost-effective biosimilar competitors, including Sandoz etanercept biosimilar, Erelzi, ...